205 related articles for article (PubMed ID: 36647548)
1. Predelivery placenta-associated biomarkers and computerized intrapartum fetal heart rate patterns.
Bowe S; Mitlid-Mork B; Gran JM; Distante S; Redman CWG; Staff AC; Georgieva A; Sugulle M
AJOG Glob Rep; 2023 Feb; 3(1):100149. PubMed ID: 36647548
[TBL] [Abstract][Full Text] [Related]
2. High early pregnancy body mass index is associated with alterations in first- and second-trimester angiogenic biomarkers.
Beck C; Allshouse A; Silver RM; Grobman WA; Simhan H; Haas D; Reddy UM; Blue NR
Am J Obstet Gynecol MFM; 2022 May; 4(3):100614. PubMed ID: 35283347
[TBL] [Abstract][Full Text] [Related]
3. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
[TBL] [Abstract][Full Text] [Related]
4. The association between placenta-associated circulating biomarkers and composite adverse delivery outcome of a likely placental cause in healthy post-date pregnancies.
Bowe S; Mitlid-Mork B; Georgieva A; Gran JM; Redman CWG; Staff AC; Sugulle M
Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1893-1901. PubMed ID: 34212381
[TBL] [Abstract][Full Text] [Related]
5. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.
Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
Am J Obstet Gynecol; 2021 Sep; 225(3):305.e1-305.e14. PubMed ID: 33812812
[TBL] [Abstract][Full Text] [Related]
6. Use of the angiogenic biomarker profile to risk stratify patients with fetal growth restriction.
Arenas GA; Tang NY; Mueller A; Lopes Perdigao J; Kaur H; Abramowicz JS; Mussatt K; Yeo KJ; Rana S
Am J Obstet Gynecol MFM; 2021 Jul; 3(4):100394. PubMed ID: 33991706
[TBL] [Abstract][Full Text] [Related]
7. Maternal serum levels of soluble fms-like tyrosine kinase-1 and placental growth factor at 20 and 28 weeks of gestational age and the risk of spontaneous preterm birth.
Sovio U; Gaccioli F; Cook E; Charnock-Jones DS; Smith GCS
Am J Obstet Gynecol; 2023 Aug; 229(2):164.e1-164.e18. PubMed ID: 36758709
[TBL] [Abstract][Full Text] [Related]
8. The additive role of angiogenic markers for women with confirmed preeclampsia.
Suresh S; Patel E; Mueller A; Morgan J; Lewandowski WL; Verlohren S; von Dadelszen P; Magee LA; Rana S
Am J Obstet Gynecol; 2023 May; 228(5):573.e1-573.e11. PubMed ID: 36356699
[TBL] [Abstract][Full Text] [Related]
9. Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian population.
Kumar N; Das V; Agarwal A; Agrawal S
AJOG Glob Rep; 2023 May; 3(2):100177. PubMed ID: 36911235
[TBL] [Abstract][Full Text] [Related]
10. Prediction of imminent preeclampsia at 35-37 weeks gestation.
Ciobanu A; Wright A; Panaitescu A; Syngelaki A; Wright D; Nicolaides KH
Am J Obstet Gynecol; 2019 Jun; 220(6):584.e1-584.e11. PubMed ID: 30738886
[TBL] [Abstract][Full Text] [Related]
11. Maternal serum soluble fms-like tyrosine kinase-1-to-placental growth factor ratio distinguishes growth-restricted from non-growth-restricted small-for-gestational-age fetuses.
Rajiv P; Cade T; Dean J; Jones GD; Brennecke SP
AJOG Glob Rep; 2024 Feb; 4(1):100302. PubMed ID: 38318268
[TBL] [Abstract][Full Text] [Related]
12. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
13. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA
Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic and vasoactive proteins in the maternal-fetal interface in healthy pregnancies and preeclampsia.
Westerberg AC; Degnes ML; Andresen IJ; Roland MCP; Michelsen TM
Am J Obstet Gynecol; 2024 Mar; ():. PubMed ID: 38494070
[TBL] [Abstract][Full Text] [Related]
15. Maternal placental growth factor and soluble fms-like tyrosine kinase-1 reference ranges in post-term pregnancies: A prospective observational study.
Mitlid-Mork B; Bowe S; Gran JM; Bolstad N; Berg JP; Redman CW; Staff AC; Sugulle M
PLoS One; 2020; 15(10):e0240473. PubMed ID: 33079955
[TBL] [Abstract][Full Text] [Related]
16. The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio).
Chaiworapongsa T; Romero R; Erez O; Tarca AL; Conde-Agudelo A; Chaemsaithong P; Kim CJ; Kim YM; Kim JS; Yoon BH; Hassan SS; Yeo L; Korzeniewski SJ
Am J Obstet Gynecol; 2017 Dec; 217(6):682.e1-682.e13. PubMed ID: 29037482
[TBL] [Abstract][Full Text] [Related]
17. Computerized data-driven interpretation of the intrapartum cardiotocogram: a cohort study.
Georgieva A; Redman CWG; Papageorghiou AT
Acta Obstet Gynecol Scand; 2017 Jul; 96(7):883-891. PubMed ID: 28369712
[TBL] [Abstract][Full Text] [Related]
18. Real-world data on the clinical use of angiogenic factors in pregnancies with placental dysfunction.
Dathan-Stumpf A; Czarnowsky V; Hein V; Andraczek T; Stepan H
Am J Obstet Gynecol; 2022 Feb; 226(2S):S1037-S1047.e2. PubMed ID: 33892922
[TBL] [Abstract][Full Text] [Related]
19. An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array.
Yagel S; Cohen SM; Goldman-Wohl D
Am J Obstet Gynecol; 2022 Feb; 226(2S):S963-S972. PubMed ID: 33712272
[TBL] [Abstract][Full Text] [Related]
20. Early pregnancy angiogenic markers and spontaneous abortion: an Odense Child Cohort study.
Andersen LB; Dechend R; Karumanchi SA; Nielsen J; Joergensen JS; Jensen TK; Christesen HT
Am J Obstet Gynecol; 2016 Nov; 215(5):594.e1-594.e11. PubMed ID: 27287686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]